Roflumilast trial shows reduced exacerbations in COPD patients
Two one-year studies of over 1,500 roflumilast-treated patients with severe COPD, chronic bronchitis and a history of exacerbations were conducted. Roflumilast treatment in patients who were frequent exacerbators
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.